Wietse S.C. Eppinga
Papers
2
Total Citations
34
H-Index
2
About
Dr. Wietse S.C. Eppinga is a leading clinician-scientist whose research focuses on the intersection of advanced molecular imaging and radiation oncology, specifically in the management of biochemically recurrent prostate cancer. His work has been instrumental in demonstrating the clinical utility of prostate-specific membrane antigen (PSMA) PET/CT, showing that its superior diagnostic accuracy leads to improved oncological outcomes for men undergoing salvage radiation therapy—a finding from his highly cited 2022 study (30 citations) that has reshaped treatment paradigms. Dr. Eppinga further refined patient selection by developing and internally validating a novel nomogram that predicts salvage therapy outcomes specifically for men without metastases on PSMA PET/CT (2024). By integrating cutting-edge imaging with personalized risk stratification, his contributions are helping to optimize salvage treatment, minimize unnecessary toxicity, and improve survival for patients with recurrent prostate cancer. His work sits at the forefront of precision oncology, bridging the gap between radiology and radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2